Cooley Advises Jazz Pharmaceuticals in Pending Acquisition of EUSA Pharma for up to $700 Million

Palo Alto, Calif. – April 26, 2012 – Cooley LLP announced today that it is advising Jazz Pharmaceuticals in its pending acquisition of EUSA Pharma.

Consideration in the deal includes $650 million in cash, subject to certain adjustments, plus a potential $50 million milestone payment in cash based upon EUSA Pharma's lead product, Erwinaze, achieving a specified U.S. net sales target in 2013.  EUSA is a privately-held, specialty pharmaceutical company with headquarters in the United States and United Kingdom.

In connection with the transaction announcement, Jazz Pharmaceuticals also announced that Barclays Bank PLC has provided it with a commitment letter for a $500 million term loan and a $100 million revolving credit facility.  Credit finance partner Gian-Michele a Marca , based in San Francisco, led the Cooley team on the financing aspects of the transaction.

The Cooley team advising on the acquisition included Palo Alto-based associates Dan Espinoza and Robin Bennett , Palo Alto-based partners Marya Postner , Glen Sato  and Barbara Kosacz , Palo Alto-based associates Jennifer Raab  and Tracy Huang Harrison , Palo Alto-based partner Mark Windfeld-Hansen , Colorado-based associate Aaron Pomeroy , Palo Alto-based partner Francis Fryscak , Washington, D.C.-based Megan Browdie , San Diego-based associates Amy Wood , Soo Kim and Megan Arthur , San Diego-based special counsel Michelle Lara , Palo Alto-based special counsel Ann Polus , Palo Alto-based partner Gregory Tenhoff , Palo Alto-based special counsel Todd Bontemps , Palo Alto-based partner Chadwick Mills and Colorado-based partner Francis Wheeler . 

The San Francisco-based Cooley team advising on the financing included associates Michael Tollini and Jason Savich .

View the company press release here .

About Cooley LLP

Cooley's 650 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters.  From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace.  The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, venture capital, clean energy, real estate and retail.

The firm has full-service offices in major business and technology centers nationwide: Palo Alto, CA, New York, NY, San Diego, CA, San Francisco, CA, Reston, VA, Broomfield, CO, Washington, DC, Boston, MA and Seattle, WA. The firm also has an office in Shanghai, China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.